N05.7 Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis

Name of the Condition

• Unspecified Nephritic Syndrome with Diffuse Crescentic Glomerulonephritis
• ICD-10 Code: N05.7

Summary

Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis is a severe kidney disorder characterized by inflammation of the glomeruli, the kidney's filtering units, with widespread crescent-shaped lesions. This condition typically presents with hematuria (blood in urine), proteinuria (excess protein in urine), reduced kidney function, and often rapid progression to kidney failure. The term "unspecified" indicates that the underlying cause is not clearly identified or documented.

Causes

The exact cause of this condition is often unclear due to the "unspecified" designation. However, it may result from immune-mediated processes, infections, or other triggers that lead to diffuse crescentic glomerular injury. In some cases, the condition may be associated with underlying diseases like vasculitis or other autoimmune disorders, though the specific cause remains undetermined.

Risk Factors

• Autoimmune conditions: Diseases such as vasculitis or lupus.
• Infections: Recent bacterial or viral infections that may trigger immune responses.
• Genetic factors: Family history of kidney disease or glomerular disorders.
• Medications: Use of drugs known to affect kidney function or induce glomerular injury.

Symptoms

• Hematuria (visible or microscopic blood in urine).
• Proteinuria (foamy or frothy urine).
• Reduced urine output or oliguria.
• Swelling (edema) in the legs, ankles, or face.
• High blood pressure (hypertension).
• Fatigue or weakness.
• Nausea or vomiting.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Urine tests may show hematuria and proteinuria. Blood tests assess kidney function (e.g., creatinine, BUN) and immune markers. A kidney biopsy is often performed to confirm diffuse crescentic glomerulonephritis and rule out other causes. Imaging studies like ultrasound may evaluate kidney size and structure.

Treatment Options

Treatment focuses on managing symptoms and addressing underlying causes if identified. Immunosuppressive medications (e.g., corticosteroids, cyclophosphamide) may be used to reduce inflammation. Blood pressure control with ACE inhibitors or ARBs is common. In severe cases, dialysis or kidney transplantation may be necessary. Supportive care includes dietary modifications and fluid management.

Prognosis and Follow-Up

Prognosis varies depending on the severity and response to treatment. Rapid intervention may improve outcomes, but some cases progress to chronic kidney disease or end-stage renal failure. Regular follow-up with nephrology is essential to monitor kidney function, adjust medications, and manage complications. Long-term care may involve ongoing immunosuppression or dialysis.

Complications

• Rapid progression to acute kidney injury or failure.
• Chronic kidney disease.
• End-stage renal disease requiring dialysis or transplantation.
• Hypertension.
• Electrolyte imbalances.
• Increased risk of infections due to immunosuppressive therapy.

Lifestyle & Prevention

• Maintain a low-sodium, kidney-friendly diet.
• Monitor and control blood pressure.
• Avoid nephrotoxic medications (e.g., NSAIDs) unless prescribed.
• Stay hydrated and manage fluid intake as advised.
• Follow up regularly with healthcare providers to monitor kidney function.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden decrease in urine output.
• Severe swelling (edema) in the legs, face, or abdomen.
• Blood in urine (visible or dark-colored).
• Uncontrolled high blood pressure.
• Persistent fatigue, nausea, or vomiting.
• Signs of infection (fever, chills) while on immunosuppressive therapy.

Tips for Medical Coders

When coding N05.7, ensure documentation supports the presence of diffuse crescentic glomerulonephritis and nephritic syndrome. Verify that biopsy or imaging findings confirm the crescentic pattern and that the cause remains unspecified. Include relevant clinical details (e.g., urine abnormalities, kidney function tests) to support the diagnosis. Avoid coding if a specific cause (e.g., vasculitis) is documented, as this may require a more precise code.